Before Header Navigation - Desktop

  • Profissionais de Saúde
  • Encontre uma Clínica
  • ACCOUNT
United Kingdom
Choose your country or region in order to display more relevant content.
Selecionar
Other country or region
Continuar
Home
Menu

V2 Main navigation

  • Iniciar
    • Iniciar
    • Eu sou elegível?
    • Reserve um horário
    • Encontre uma clínica
  • Como funciona
    • Como funciona
    • O programa
    • A ciência
    • Os resultados
  • Histórias de sucesso
  • Perguntas frequentes
    • FAQs
    • Blog
  • Reserve uma consulta
  • Profissionais de Saúde
  • Pacientes
  • Encontre uma Clínica
Ip Address
3.15.198.191
Country
United States of America
Country Code
US

Referências

  • *As with any medical solution, results may vary from one patient to another, and some patients may not respond to treatment. Please consult a doctor to carefully evaluate the risks and benefits before making your decision.
  • **Some patients may experience earlier deflation of the Allurion Balloon. The removal of the Allurion Balloon may, in very rare cases, require an endoscopic or surgical intervention. In rare cases, instead of being expelled through the digestive tract, the empty balloon may be vomited out.
  • ***Eligibility for the placement of an Allurion Balloon will be assessed by a certified doctor after an initial consultation and a careful review of your medical history. In the case of an extended Allurion Program, your eligibility is reassessed before each placement to ensure you continue to meet the required conditions.
  1. R. Ienca et al. The procedureless ellipse gastric balloon program: Multicenter experience in 1770 consecutive patients. Obes surg. 2020;30(9):3354-3362. Multicenter, prospective, non-randomized, open registry study conducted in patients with overweight or obesity from January 2016 to June 2019 in 19 international obesity centers participating in the study. A total of 1,770 patients with an average BMI of 34.4 ± 5.3 kg/m2 at baseline underwent treatment with the Elipse swallowable gastric balloon, with a monthly visit and a total follow-up of 4 months. 63 patients (3.6%) did not complete the program, and the balloon was removed before 4 months due to intolerance or other adverse effects.
  2. World Health Organization – Key facts on Obesity and overweight (who.int).
  3. European survey finds over three-quarters of adults with obesity have attempted to lose weight in the past year, but most have been unsuccessful – EASO.
  4. This information is extracted from the instructions for use of the Allurion Gastric Balloon System. Version number CS137-02-ENG. If you have any questions regarding this document, please consult your doctor.

Sobre a Allurion

Allurion Technologies se dedica a acabar com a obesidade criando a primeira plataforma do mundo para perda de peso em pilha completa. No centro desta plataforma está o Programa Allurion, uma experiência de perda de peso de 360 graus com o Allurion Gastric Balloon -- o primeiro e único balão gástrico do mundo engolível e sem procedimentos para perda de peso -- e o Allurion Virtual Care Suite incluindo o Allurion Mobile App para consumidores, Allurion Insights para clínicos com a Plataforma Iris AI, e os dispositivos Allurion Connected Scale e Health Tracker. O Allurion VCS está agora disponível para provedores separadamente do Programa Allurion para ajudar a personalizar, monitorar e gerenciar a terapia de perda de peso para pacientes, independentemente de seu plano de tratamento: balão gástrico, cirúrgico, médico ou nutricional. Saiba mais sobre Allurion online em www.allurion.com. Allurion é uma marca registrada da Allurion Technologies, Inc. nos Estados Unidos e em países de todo o mundo.

Footer

  • Conheça a Equipe
  • Nossa História
  • Carreiras
  • Encontre uma Clínica
  • Blog
  • As Nossas Patentes
  • Politica de privacidade
  • Qualidade & Riscos
  • Termos de Uso
  • Mapa do site
  • Torne-se uma clínica parceira
© Allurion 2025

Social links

  • Facebook
  • YouTube
  • Instagram
  • LinkedIn

click me

Chat with Ally